U.S. sends experimental antibody, antiviral drug for Ebola outbreak
So far, 60 infected and 44 dead.
U.S. sends experimental antibody, antiviral drug to Uganda for Ebola outbreak
Julie Steenhuysen
CHICAGO, Oct 18 (Reuters) - The United States sent Gilead Sciences' remdesivir and Mapp Biopharmaceutical Inc's experimental Ebola antibody drug MBP134 to Uganda last week to help safeguard healthcare workers responding to an outbreak that has infected 60 peopl…
Keep reading with a 7-day free trial
Subscribe to Global Community Weekly (GloCom) to keep reading this post and get 7 days of free access to the full post archives.